Viewing Study NCT06373666



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06373666
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-07
First Post: 2024-04-16

Brief Title: A Study to Evaluate the Adjustment Function of a Modified Spatz3 Adjustable Balloon Spatz4
Sponsor: Spatz FGIA Inc
Organization: Spatz FGIA Inc

Study Overview

Official Title: A Study to Evaluate the Adjustment Function of a Modified Spatz3 Adjustable Balloon Spatz4
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the function of the adjustment procedure with the Spatz4 in subjects with a BMI 27
Detailed Description: The purpose of this study is to evaluate the function of the adjustment procedure with the Spatz4 in subjects with a BMI 27

Subjects will be studied in an open label study that will have one endpoint at 20 weeks Up to 20 eligible subjects will undergo endoscopy and those without endoscopic contraindications will be implanted with the Spatz4 balloon All subjects will follow a calorie restricted diet designed by the dietician The initial diet will be liquid and will be advanced as per the dieticians recommendations Changes in diet will depend on subject tolerance to the balloon and specific food intolerances and will be adjusted frequently by the dietician The initial balloon volume will be 450 to 550 ml of 09 normal saline with 2 ml of a 1 solution of methylene blue It is estimated based on clinical studies that approximately 10 of subjects will be intolerant in the first month and will require a down adjustment wherein 150 ml of fluid will be removed from the balloon An up adjustment will be performed at 16 weeks 2 weeks with the addition of 200-300 ml of 09 normal saline as per section 172133 The balloon adjustment procedure is done with an endoscopy procedure under the same sedation as the implantation procedure The subjects will be followed for 2 weeks after the up-adjustment procedure after which the study ends Subjects will be given the option to continue the implantation period until 52 weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None